Navigation Links
Florastor(R) Receives Certification

Independent Testing Organization Finds Saccharomyces boulardii Product from

Biocodex Inc. Meets all Probiotic Testing Criteria

SAN BRUNO, Calif., March 11 /PRNewswire/ -- After undergoing intensive voluntary testing, Florastor(R), the world's top-selling probiotic supplement, has been named to the list of Approved Quality products on, the leading provider of independent test results and information to help consumers and healthcare professionals evaluate health, wellness and nutrition products.

(Photo: )

"We are thrilled that Florastor has been recognized by as an Approved Quality probiotic supplement," says Mary Berry, U.S. marketing manager at Biocodex, Inc., the France-based manufacturer of the product. "Its passing status confirms our claims that Florastor contains 10 billion live probiotic organisms, which is essential in the product's promotion of healthy intestinal function through the balance of intestinal flora."

Prior to its testing of Florastor,, which records more than three million Web site visits per year, had posted a report in December 2006 on quality testing done on a randomly selected group of probiotic supplements. The testing criteria included identifying the number of live microorganisms in the product to both determine that it matched the number noted on the product's packaging and if there were at least one billion live microorganisms in the product (the generally accepted minimum amount needed to deliver any significant health benefit). The report revealed that only eight of 13 probiotic products selected by actually contained the labeled amounts of live microorganisms, and several did not meet the one billion minimum.

Products were also tested for the lack of contaminating organisms, as well as the enteric protection of the product, meaning the microorganisms' ability to survive as they make their way through stomach acid and into the small intestine where bacteria would flourish.

"Florastor is the most widely used probiotic in the world and is the product of extensive and ongoing research," says Berry. "It is very important to us that its claims have been validated by a reputable third party so that U.S. consumers can have confidence in the product."

Florastor, which utilizes a freeze-dried form of a beneficial yeast called Saccharomyces boulardii (S. boulardii), was voluntarily submitted for testing and passed the organization's review criteria by meeting its listed number of 10 billion probiotic organisms in a maximum suggested daily serving, as well as being free of microbial contamination and exhibiting sufficient enteric protection.

Florastor is supported by numerous clinical studies and is the only probiotic mentioned by the World Health Organization (WHO) for use in managing recurrent disease associated with the Clostridium difficile (C. diff) infection(1). It is clinically proven to be effective in helping to manage intestinal issues ranging from acute diarrhea to chronic inflammatory conditions (such as Crohn's disease or ulcerative colitis). Florastor has also been clinically proven to be particularly effective in combating antibiotic-associated diarrhea, since, unlike bacteria-based probiotics, the beneficial yeast in Florastor cannot be killed by the antibiotic treatment itself.

Probiotics are defined by the Food and Agriculture Organization (FAO) of the United Nations, as "live microorganisms administered in adequate amounts, which confer a beneficial health effect on the host." Florastor has shown in more than 50 years of extensive international use to be safe and effective, with an estimated 1.7 billion daily doses sold to date.

Florastor is available in most retail chain pharmacies, and at independent pharmacies. It can be purchased in bottles of 10 capsules for a suggested price of $9.95, or 50 capsules for a suggested price of $39.95. Florastor Kids is available in a box of 10 powder packets (which can be mixed with applesauce or beverages, including infant formula) for a suggested price of $11.95, or in a 20-packet box for a price of $19.95.

Visit to find out where to purchase Florastor in your area. It is commonly found in the anti-diarrheal/stomach aid section, and can also be obtained by asking the pharmacist (many stores keep Florastor the product behind the counter). It can also be purchased online at

For more information on testing, visit

(1) Saccharomyces boulardii: a valuable adjunct in recurrent Clostridium

difficile disease? (1995) WHO Drug Information; 9;(1); 15-16.

SOURCE Florastor
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. DuraHeart(TM) LVAS Receives Conditional Approval for US Pivotal Trial
2. Vermillion Receives Award From the Society of Gynecologic Oncologists
3. Arbios Receives Conditional Approval from the FDA to Initiate Pivotal Clinical Trial for SEPET(TM)
4. ActivBiotics Receives Orphan Drug Designation from the European Medicines Agency for Superoxide Dismutase Mimetic, M40403, in Oral Mucositis Indication
5. Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency
6. Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
7. Photo: Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
8. Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
9. Abbotts HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis
10. Vical Receives Payment from AnGes MG for Allovectin-7(R) Phase 3 Pivotal Trial
11. Fovea Pharmaceuticals Receives Orphan Drug Designation from EC for RdCVF for the Treatment of Retinitis Pigmentosa
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 ... addition of the "2016 Future Horizons ... of Abuse Testing Market: Supplier Shares, Country ... report to their offering. --> ... the "2016 Future Horizons and Growth ...
(Date:11/26/2015)... ) has announced ... High Viscosity Drugs" report to their offering. ... addition of the "Self Administration of High ... --> Research and Markets ( ) ... Administration of High Viscosity Drugs" report to ...
(Date:11/25/2015)... 2015  The total global healthcare industry is expected to ... Latin America has the highest projected growth ... Japan ), is second with growth projected at ... increased healthcare expenditure. In 2013-2014, total government funded healthcare was ... 2008-2009 to 41.2% in 2013-2014. In real terms, out of ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... ... 27th edition of USA Today in Atlanta, Dallas, New York, Minneapolis, South Florida, ... The digital component is distributed nationally, through a vast social media strategy and ...
(Date:11/27/2015)... ... November 27, 2015 , ... Intellitec Solutions announced today ... Group (MSDSLUG). Recognized as Microsoft’s official group for end users of Dynamics SL ... users, partners, industry experts and representatives. Intellitec Solutions’ membership status demonstrates their ongoing ...
(Date:11/27/2015)... ... 2015 , ... CBD College is proud to announce that on ... accreditation to its Diagnostic Medical Sonography program. CBD College is honored to join this ... colleges and universities in the state of California make the cut. CBD College is ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft Inc., developer ... incorporation of Asterisk 11 LTS (Long Term Support) into its Q-Suite 5.10 product ... Q-Suite 5.10 up-to-date with a version of Asterisk that will receive not only ...
(Date:11/26/2015)... ... November 26, 2015 , ... Somu Sivaramakrishnan announced today that ... Somu now offers travelers, value and care based Travel Services, including exclusive pricing ... well as, cabin upgrades and special amenities such as, shore excursions, discounted fares, ...
Breaking Medicine News(10 mins):